Hemodynamic Monitoring System Market Size, Share, and COVID-19 Impact Analysis By Product (Hardware {Monitors, Sensors, Oximetry Catheters, and Others} and Software), By Type (Invasive and Non-invasive), By End-User (Hospital & ASCs, Specialty Clinics, and Others), and Regional Forecast, 2025-2032

Hemodynamic monitoring systems refer to devices that measure blood flow, pressure, and oxygenation within the cardiovascular system, particularly in critically ill patients. Hemodynamic monitoring maintains adequate arterial pressure along with optimal oxygen delivery and tissue perfusion among patients. The increasing prevalence of cardiovascular diseases and diabetes resulted in increasing inpatient and outpatient admissions within hospitals and clinics. The surging number of patient admissions is contributing to the growing adoption of hemodynamic monitoring systems among the patient population.

• For instance, according to 2023 data published by the Centers for Disease Control & Prevention (CDC), it was reported that about 1 in 20 adults aged 20 and older have cardiovascular diseases.

Additionally, governments are placing a rising emphasis on promoting the advancement of products for critically ill patients owing to the increasing prevalence of cardiovascular diseases and others among patients. Furthermore, increasing awareness of these devices is further driving the focus of key players on research and development activities to launch advanced products, contributing to the growth of the market.

• In June 2023, Mindray Medical partnered with Edwards Lifesciences to launch technologically advanced BeneVision N series patient monitors in Europe with an aim to increase its product offerings.

The growing demand for patient monitoring devices in emerging countries, such as Brazil, Mexico, and others, is leading the key players to focus on expanding their geographical reach to increase their brand presence in the market. Thus, increasing product demand and the growing awareness of these devices are expected to propel the market growth.

Impact of COVID-19 on the Hemodynamic Monitoring System Market

The COVID-19 pandemic positively influenced the hemodynamic monitoring system market. The increasing prevalence of cardiovascular diseases and diabetes resulted in the growing diagnosis rate among patients during the pandemic. This, along with COVID-19 complications such as low oxygen rate, sepsis, and others, resulted in an increased demand for patient monitoring systems for critically ill patients, positively driving the growth of the market.  

• For instance, according to a 2022 article published by the National Center for Biotechnology Information (NCBI), it was reported that sepsis was present in about 65 patients out of every 200 patients during COVID-19 hospitalizations.

Furthermore, the increasing focus of key players on research and development activities to launch hemodynamic monitoring systems to cater the growing demand among the patient population contributed to the industry growth during the pandemic.

Segmentation

Key Insights

The report covers the following key insights:

• Prevalence of Cardiovascular Diseases, By Key Countries/ Region, 2022
• Technological Advancements in Hemodynamic Monitoring System Devices
• New Product Launches, By Key Players
• Key Industry Developments - Partnerships, Mergers, and Acquisitions
• Impact of COVID-19 on the Global Hemodynamic Monitoring System Market

Analysis by Product

Based on product, the market is bifurcated into hardware and software. The hardware segment is further subdivided into monitors, sensors, oximetry catheters, and others. Amongst these, the hardware segment is anticipated to hold a dominant position in the hemodynamic monitoring system market. The increasing focus of key players on launching advanced monitors, oximetry catheters, and other products for efficient and accurate monitoring of hemodynamics within patients is supporting the growing adoption of these systems in the market. Along with this, increasing government focus on patient-centric care for critically ill patients is expected to increase the demand for monitors among the key players, thereby contributing to the growth of the segment.

• For instance, in May 2021, Royal Philips integrated its Interventional Hemodynamic System with its portable Patient Monitor IntelliVue X3 with an aim to expand its global product portfolio.

The software segment is anticipated to register considerable growth during the forecast period. This is attributed to the increasing awareness about these devices, which has resulted in the growing number of players investing in R&D activities to launch novel software providing accurate and real-time data among patients. The increasing integration of this software with advanced devices such as oximetry catheters and others, resulting in the rising adoption of these devices, is expected to support the segment growth.

Regional Analysis

To gain extensive insights into the market, Download for Customization

North America holds the largest share in the market due to the increasing prevalence of cardiovascular diseases and others, resulting in growing inpatient admissions. Additionally, advanced healthcare infrastructure and the growing focus on technological advancements for these hemodynamic monitoring systems, is anticipated to fuel the growth of the region in the market.  

The Europe and Asia Pacific markets are anticipated to grow due to the increasing focus on healthcare spending to cater to the increasing demand for advanced patient monitoring systems for critically ill patients. The increasing geriatric population and rising government focus on promoting advancements in patient monitoring systems further increases the adoption of hemodynamic control systems, thereby driving the market growth.

Key Players

The report includes the profiles of key players such as Baxter, GE Healthcare, Masimo, Edwards Lifesciences Corporation, Deltex Medical Limited, ICU Medical, Koninklijke Philips N.V., and others.

Key Industry Developments

• In October 2023, Masimo received CE approval for the LiDCO board-in-cable (BIC) module in hemodynamic monitoring with an aim to expand its product offerings for hemodynamic monitoring systems.

In April 2022, Caretaker Medical received FDA approval for a wireless wearable monitor for continuous blood pressure and advanced hemodynamics with an aim to strengthen its product portfolio worldwide.